ANI Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	285.59	144.86	221.12	48.23	100.3
Short-Term Investments	9.13	6.31	-	-	-
Cash & Short-Term Investments	294.72	151.17	221.12	48.23	100.3
Cash Growth	94.96%	-31.64%	358.49%	-51.92%	1175.43%
Receivables	281.08	221.73	162.08	165.44	128.53
Inventory	143.07	136.78	111.2	105.36	81.69
Prepaid Expenses	23.19	17.78	17.4	8.39	7.59
Restricted Cash	0.04	0.03	-	5.01	-
Other Current Assets	11.03	0.2	8.02	11.85	3.67
Total Current Assets	753.12	527.68	519.82	344.26	321.78
Property, Plant & Equipment	62.48	56.86	44.59	43.25	52.67
Long-Term Investments	-	4.9	6.24	8.8	-
Goodwill	62.48	59.99	28.22	28.22	27.89
Other Intangible Assets	479.53	541.83	209.01	251.64	294.12
Long-Term Deferred Tax Assets	69.07	85.11	90.71	81.36	67.94
Long-Term Deferred Charges	-	0.9	-	-	-
Other Long-Term Assets	13.71	6.42	5.84	2.56	7.21
Total Assets	1,440	1,284	904.42	760.09	771.6
Accounts Payable	62.58	45.66	36.68	29.31	22.97
Accrued Expenses	146.35	90.76	57.84	35.89	27.89
Short-Term Debt	17.27	-	-	-	-
Current Portion of Long-Term Debt	-	9.17	0.85	0.85	0.85
Current Portion of Leases	-	2.04	-	-	-
Current Income Taxes Payable	2.24	6.75	8.16	-	-
Other Current Liabilities	49.67	39.3	41.94	33.4	35.83
Total Current Liabilities	278.11	193.68	145.48	99.44	87.54
Long-Term Debt	599.77	614.92	284.82	285.67	286.52
Long-Term Leases	-	4.55	-	1.38	-
Other Long-Term Liabilities	21.77	42.02	16.53	35.06	38.8
Total Liabilities	899.65	855.17	446.82	421.55	412.86
Common Stock	0	0	0	0	0
Additional Paid-In Capital	596.04	519.65	514.1	403.9	387.84
Retained Earnings	-23.1	-100.28	-80.13	-97.29	-47.77
Treasury Stock	-33.25	-21.04	-10.08	-5.09	-3.14
Comprehensive Income & Other	1.03	5.34	8.86	12.17	-3.06
Total Common Equity	540.72	403.68	432.75	313.69	333.89
Shareholders' Equity	540.72	428.53	457.6	338.54	358.74
Total Liabilities & Equity	1,440	1,284	904.42	760.09	771.6
Total Debt	617.04	630.68	285.67	287.9	287.37
Net Cash (Debt)	-322.32	-479.51	-64.55	-239.67	-187.07
Net Cash Per Share	-15.18	-24.82	-3.55	-14.74	-14.85
Filing Date Shares Outstanding	22.41	20.31	19.72	16.35	16.55
Total Common Shares Outstanding	22.49	19.65	19.12	16.35	16.12
Working Capital	475.01	334	374.34	244.82	234.24
Book Value Per Share	24.04	20.54	22.64	19.18	20.71
Tangible Book Value	-1.28	-198.14	195.52	33.83	11.88
Tangible Book Value Per Share	-0.06	-10.08	10.23	2.07	0.74
Land	-	1.58	1.55	1.55	5.95
Buildings	-	24.44	17.88	16.66	19.97
Machinery	-	68.7	50.41	53.15	46.77
Construction In Progress	-	4.57	7.69	4.6	2.94
Leasehold Improvements	-	1.3	-	-	-

Updated Feb 27, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q